167 related articles for article (PubMed ID: 35348331)
1. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
[TBL] [Abstract][Full Text] [Related]
2. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
[TBL] [Abstract][Full Text] [Related]
3. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
[TBL] [Abstract][Full Text] [Related]
4. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
[No Abstract] [Full Text] [Related]
5. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
[TBL] [Abstract][Full Text] [Related]
6. Self-accelerating H
Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z
Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272
[No Abstract] [Full Text] [Related]
7. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
[TBL] [Abstract][Full Text] [Related]
8. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
[TBL] [Abstract][Full Text] [Related]
9. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
[TBL] [Abstract][Full Text] [Related]
10. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract][Full Text] [Related]
11. Prodrug and Glucose Oxidase Coloaded Photodynamic Hydrogels for Combinational Therapy of Melanoma.
Zhou J; Liu C; Wang Y; Ding M; Yu N; Liu D; Zhang Q; Li J
ACS Biomater Sci Eng; 2022 Nov; 8(11):4886-4895. PubMed ID: 36278808
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
13. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
14. pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy.
Du C; Wang C; Jiang SH; Zheng X; Li Z; Yao Y; Ding Y; Chen T; Yi H
Biomater Sci; 2023 Aug; 11(16):5674-5679. PubMed ID: 37439102
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
16. Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy.
Zhang MK; Li CX; Wang SB; Liu T; Song XL; Yang XQ; Feng J; Zhang XZ
Small; 2018 Dec; 14(50):e1803602. PubMed ID: 30370690
[TBL] [Abstract][Full Text] [Related]
17. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
18. A bioresponsive diselenide-functionalized hydrogel with cascade catalytic activities for enhanced local starvation- and hypoxia-activated melanoma therapy.
Ding X; Zang M; Zhang Y; Chen Y; Du J; Yan A; Gu J; Li Y; Wei S; Xu J; Sun H; Liu J; Yu S
Acta Biomater; 2023 Sep; 167():182-194. PubMed ID: 37339693
[TBL] [Abstract][Full Text] [Related]
19. A Glucose/Oxygen-Exhausting Nanoreactor for Starvation- and Hypoxia-Activated Sustainable and Cascade Chemo-Chemodynamic Therapy.
Guo Y; Jia HR; Zhang X; Zhang X; Sun Q; Wang SZ; Zhao J; Wu FG
Small; 2020 Aug; 16(31):e2000897. PubMed ID: 32537936
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]